EP Patent

EP4096648A4 — Methods and compositions for the treatment of hemangioma

Assigned to Gillies Mcindoe Research Institute · Expires 2024-02-28 · 2y expired

What this patent protects

Patent listed against propranolol-hydrochloride.

Drugs covered by this patent

propranolol-hydrochloride (PROPRANOLOL HYDROCHLORIDE)

Patent Metadata

Patent number: EP4096648A4
Jurisdiction: EP
Classification: —
Expires: 2024-02-28
Drug substance claim: No
Drug product claim: No
Assignee: Gillies Mcindoe Research Institute
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.